Podcasts | Interviews
/ Going Viral: Critical perspectives on the current Australian COVID response, Monkeypox and a few other things
Going Viral: Critical perspectives on the current Australian COVID response, Monkeypox and a few other things
Going Viral: Critical perspectives on the current Australian COVID response, Monkeypox and a few other things

Going Viral: Critical perspectives on the current Australian COVID response, Monkeypox and a few other things

Description

Going Viral Episode 194: Critical perspectives on the current Australian COVID response, Monkeypox and a few other things

 

In this episode:

 

 

– We should begin transitioning our patients to Novavax and protein-based vaccines and away from mRNA
– Monkeypox should be taken seriously… especially for high-risk patients
– New viruses are emerging so we need to reinforce the importance of ongoing personal hygiene
– The previous government has significantly undermined our capacity to deal with serious public health issues

 

 

Order industry samples

 
Host: Dr David Lim, GP and Medical Educator

 

 

Total time: 38 mins

 

 

Guest: Dr Gary Grohmann, Virologist and Vaccine Manufacturing Expert

 

 

 
 
 

 

Log your own CPD by following these easy steps:
– Listen to 30 minutes of Healthed podcasts
– Click on the Quick Log logo and follow the link to the RACGP website
– Log in to your myCPD dashboard
– Click on the Quick Log function to log your points
– A 30 minute podcast earns 1 CPD point

 

 

 

Enjoy this content?
Each fortnight, Healthed hosts a free webcast featuring leading experts on important topics for healthcare professionals. Register for the upcoming webcast by clicking the button below.

Register for the free webcast



Speaker

Dr Gary Grohmann

Virologist; Vaccine Manufacturing Expert; Former Director of Immunobiology and WHO ERL at the TGA, Office of Laboratories and Scientific Services

Show Information


Dr. Gary Grohmann B. Sc. (Hons), PhD, FASM Gary Grohmann is former Director of Immunobiology and WHO ERL at the TGA, Office of Laboratories and Scientific services from 1997-2015. He currently works as an independent consultant, primarily with the WHO on influenza related projects in the Global Influenza Programme and the Essential Medicines Programme.
Dr. Grohmann has served on several WHO steering committees including the committee for the review of the IVTM database on influenza viruses and reassortant influenza viruses, and the WHO VCM committee that recommends virus strains for influenza vaccines (until 2015). He has also been a member of the Technical Advisory Group (2007-2015) of the Global Action Plan for Influenza.
His primary interests are in vaccines, vaccine regulation, medical and veterinary virology, and infectious diseases resulting from contaminated food and water as well as other environmental sources. Dr. Grohmann is currently a Director of Environmental Pathogens P/L as well as Director/Board Member of the Immunisation Coalition and has held a number of part-time academic positions in his career at The University of Sydney, The University of Technology, Sydney, and The University of NSW.

Recommended
Clinical Articles

Pox shock! – Monkeypox

 

Just when you thought we had had our fill of infectious diseases, along comes a virus that ...

Read more
Monographs

Acute Pain Management
The following article will summarise relevant and new findings regarding Acute Pain Management, including the use of analgesics ...
Read more
  • This field is for validation purposes and should be left unchanged.
Send this to a friend